(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OSE-CYTOMASK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OSE-CYTOMASK

ST13

US500000098098883

Class

42

Filing

98098883

Registration

7782135

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

05/07/2025

Trademark type

Word

Nice classes

42

Filing date

07/24/2023

Registration date

05/06/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/06/2025

Last transaction

05/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

11

Owner location

Nantes, FR

Examiner

KHOURI, SANI

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

O. I. (pessoa física)

Representatives

Mary Grieco Lee OLSHAN FROME WOLOSKY LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological servicesresearch and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganismscells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/06/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/18/2025

PUBO

PUBLISHED FOR OPPOSITION

03/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/28/2025

PUBO

PUBLISHED FOR OPPOSITION

01/28/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/22/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2024

ALIE

ASSIGNED TO LIE

12/11/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/08/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/05/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/05/2024

CNSI

SUSPENSION INQUIRY WRITTEN

11/05/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

10/25/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/28/2023

GNSL

LETTER OF SUSPENSION E-MAILED

11/28/2023

CNSL

SUSPENSION LETTER WRITTEN

11/28/2023

DOCK

ASSIGNED TO EXAMINER

11/26/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/22/2023

NWAP

NEW APPLICATION ENTERED

07/27/2023

Continuous trademark protection

Get notified about every new filing that threatens OSE-CYTOMASK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.